Willow Creek Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$346K Sell
453
-14
-3% -$10.4K 0.03% 128
2025
Q2
$364K Buy
467
+8
+2% +$6.22K 0.03% 120
2025
Q1
$379K Sell
459
-11
-2% -$9.15K 0.04% 107
2024
Q4
$363K Sell
470
-10
-2% -$8.28K 0.04% 111
2024
Q3
$425K Hold
480
0.04% 99
2024
Q2
$435K Sell
480
-11
-2% -$8.8K 0.05% 92
2024
Q1
$382K Buy
491
+11
+2% +$7.83K 0.04% 103
2023
Q4
$280K Buy
480
+3
+0.6% +$1.75K 0.04% 118
2023
Q3
$256K Sell
477
-28
-6% -$14.4K 0.04% 117
2023
Q2
$237K Buy
+505
New +$212K 0.03% 129
2022
Q4
Sell
-628
Closed -$203K 134
2022
Q3
$203K Buy
+628
New +$199K 0.04% 115

Other funds holding LLY

Willow Creek Wealth Management's LLY Position: Q3 2025 in Review

Willow Creek Wealth Management reduced its Eli Lilly (LLY) stake by 3% in Q3 2025, selling an estimated $10.4K and leaving 453 shares worth $346K. The position accounts for 0.03% of the portfolio, ranked #128.

Willow Creek Wealth Management first reported a position in LLY in Q3 2022 and has held it in 11 quarters since. The position peaked at $435K in Q2 2024. 3,903 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Willow Creek Wealth Management held 453 shares of Eli Lilly worth $346K as of Q3 2025.
  • Willow Creek Wealth Management sold 14 Eli Lilly shares in Q3 2025, an estimated $10.4K.
  • Eli Lilly made up 0.03% of Willow Creek Wealth Management's portfolio in Q3 2025, its #128 holding.
  • Willow Creek Wealth Management first reported a position in Eli Lilly in Q3 2022 and has held it in 11 quarters since.
  • Willow Creek Wealth Management's Eli Lilly position peaked at $435K in Q2 2024.
  • 3,903 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Willow Creek Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.